Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2013 | 04-2013 | 01-2013 | 10-2012 | 07-2012 | |
| Sales | 3,020 | 1,784 | 2,917 | 1,458 | 2,106 |
| Cost of Goods | 1,671 | 1,549 | 1,242 | 1,057 | 1,471 |
| Gross Profit | 1,349 | 235 | 1,675 | 401 | 635 |
| Operating Expenses | 2,786 | 2,896 | 2,637 | 2,374 | 2,705 |
| Operating Income | -766 | -2,112 | -720 | -1,916 | -1,599 |
| Other Income | -1,463 | -55 | -265 | -57 | 279 |
| Pre-tax Income | -2,229 | -2,167 | -985 | -1,973 | -1,320 |
| Income Tax | 3 | 1 | 5 | 1 | 3 |
| Net Income Continuous | -2,232 | -2,167 | -990 | -1,974 | -1,323 |
| Net Income | $-2,232 | $-2,167 | $-990 | $-1,974 | $-1,323 |
| EPS Basic Total Ops | -0.36 | -0.36 | -0.24 | -0.48 | -0.36 |
| EPS Basic Continuous Ops | -0.40 | -0.37 | -0.25 | -0.50 | -0.34 |
| EPS Diluted Total Ops | -0.36 | -0.36 | -0.24 | -0.48 | -0.36 |
| EPS Diluted Continuous Ops | -0.40 | -0.37 | -0.25 | -0.50 | -0.34 |
| EBITDA(a) | $-716 | $-2,062 | $-670 | $-1,867 | $-1,545 |